Babies Born Following Administration of Nolasiban Before Embryo Transfer (ET) After IVF: Neonatal and Infant Development Outcomes From a Double-Blind, Placebo-Controlled, Clinical Trial

October 7, 2019

Nolasiban

Humberstone A., Terrill P., Macgregor L., Loumaye E. ASRM 2019 Scientific Congress & Expo, 12-16 October 2019, Philadelphia, PA Fertility…

Read more

Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium

April 8, 2019

Nolasiban

Sung Hye Kim, Lucia Riaposova, Hauwa Ahmed, Oliver Pohl, André Chollet, Jean-Pierre Gotteland, Aylin Hanyaloglu, Phillip R. Bennett & Vasso…

Read more

A Placebo-Controlled, Randomized, Double-Blind, Phase 3 Study Assessing Ongoing Pregnancy Rates After Single Oral Administration of a Novel Oxytocin Receptor Antagonist, Nolasiban, Prior to Single Embryo Transfer

October 9, 2018

Nolasiban

Visnova H., Tournaye H. J., Humberstone A., Terrill P., Macgregor L., Loumaye E. ASRM 2018, 6-10 October 2018, Denver, CO

Read more

Effects of the oral oxytocin receptor antagonist nolasiban on early embryonic development

July 4, 2018

Nolasiban

O. Pohl, D. Perks, R. Sisti, J.P. GottelandESHRE Annual Conference, 01-04 July 2018, Barcelona, Spain

Read more

ObsEva on page 17 of Understanding Fertility Special Report 2018

April 24, 2018

Nolasiban

Special report in the Raconteur Article in ‘The Times’ Click here for publication link IVF ‘BREAKTHROUGH’ TREATMENT Pioneering use of…

Read more

A placebo-controlled, randomized, double-blind study of pregnancy and live birth rates after single oral administration of a novel oxytocin antagonist, nolasiban, prior to embryo transfer

July 5, 2017

Nolasiban

H. Tournaye, A. Humberstone, V. Lecomte, P. Terrill, P. Pierzynski, E. Loumaye ESHRE 33rd Annual Meeting, 2-5 July 2017, Geneva,…

Read more

Combination tocolytics on the inhibition of OT-induced contractions of human pregnant myometrium in vitro

Nolasiban

L. Riaposova, S.H. Kim, O. Pohl, A. Chollet, J.P. Gotteland, A. Hanyaloglu, P. Bennett, V. Terzidou ESHRE 33rd Annual Meeting,…

Read more

FP receptor antagonist, OBE002, inhibits both PGF2α- and OT-induced contractions of human pregnant myometrium in vitro

Nolasiban

L. Riaposova, S.H. Kim, O. Pohl, A. Chollet, J.P. Gotteland, A. Hanyaloglu, P. Bennett, V. Terzidou ESHRE 33rd Annual Meeting,…

Read more

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium

April 1, 2017

Nolasiban

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium Sung Hye…

Read more

Both OTR Antagonists, Atosiban and Nolasiban, Inhibits PGE2/PGF2α-Induced Contractions of Human Pregnant Myometrium In Vitro.

March 18, 2017

Nolasiban

Sung Hye Kim, Hauwa Ahmed, Lucia Riaposova, Oliver Pohl, Andre Chollet, Aylin Hanyaloglu, Phillip R Bennett, Vasso Terzidou SRI Conference,…

Read more